Cooper-Standard vs Dorman Products
CPS and DORM side by side, both in motor vehicles and motor vehicle equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CPS and DORM compare
Dorman Products is the larger company, worth 12 times as much as Cooper-Standard ($4.0B against $336M).
Cooper-Standard grew revenue faster over the last twelve months (27.9% versus 2.2% for Dorman Products).
Dorman Products keeps more of each dollar of sales as profit, with a net margin of 9.3% compared with −1.7% at Cooper-Standard.
Dorman Products scores higher on the StockData Score (13 against 5 for Cooper-Standard), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CPS | DORM |
|---|---|---|
| Size and price | ||
| Market cap | $336M | $4.0B |
| Share price | $18.93 | $134.55 |
| Change, 1 year | −34.4% | 0.40% |
| Change, 5 years | −21.8% | 14.0% |
| Beta (5Y) | 2.35 | 0.68 |
| Employees | 22K | 300 |
| StockData Score | ||
| Total score | 5 | 13 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 1 | 5 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 20.0× |
| P/S | 0.1× (better) | 1.8× |
| P/B | – | 2.5× |
| EV/EBITDA | 13.4× | 12.3× (better) |
| P/FCF | – | 14.7× |
| PEG | – | 1.00 |
| FCF yield | −8.4% | 6.8% (better) |
| Fair value | – | $113.99 |
| Margin of safety | – | −18.0% |
| Growth | ||
| Revenue growth (TTM) | 27.9% (better) | 2.2% |
| Revenue growth, 5Y average | – | 14.3% |
| Net income growth (TTM) | – | −18.2% |
| EPS growth (TTM) | – | −16.3% |
| EPS growth, 5Y average | – | 15.0% |
| Profitability | ||
| Gross margin | 12.0% | 41.1% (better) |
| Operating margin | 2.9% | 13.3% (better) |
| Net margin | −1.7% | 9.3% (better) |
| FCF margin | −0.81% | 12.4% (better) |
| Return on equity | – | 13.3% |
| Return on invested capital | 9.3% | 11.5% (better) |
| Financial health | ||
| Debt / equity | – | 0.28 |
| Net debt / EBITDA | 10.21 | 0.79 (better) |
| Interest coverage | – | 10.8× |
| Current ratio | 1.31 | 3.65 (better) |
| Altman Z-score | 1.85 | 4.95 (better) |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 64.9% | 97.6% |
| Held by insiders | 5.5% | 8.2% |
| Insider net buying, 12 months | $225K (better) | −$1.7M |
| Short interest, % of float | 4.5% | 5.7% |
Go deeper
- CPS stock overview
- CPS income statement
- CPS valuation and score
- DORM stock overview
- DORM income statement
- DORM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.